EuroWeek View: European levloan repricings show market’s health
European leveraged loan investors are revolting — resisting margin reduction requests for Iceland and Global Blue and winning concessions. But rather than suggesting that this is symptomatic of a failing product, the amendments won by the buyside actually illustrate the health of the leveraged loan market. And just in time, as the forthcoming Heinz deal means that the sector is facing its greatest challenge in years.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
